The Cancer Registry of the UCSF Helen Diller Family Comprehensive Cancer Center makes available the following materials for UCSF investigators and other interested individuals. For assistance or questions, please contact Ann Griffin, Cancer Registry Manager, at 415.353.9700 or by email.

Statistical Reports (PDF)
Statistical Report: 2004 (includes "A Closer Look: Thyroid")
Statistical Report: 2003 (includes "A Closer Look: Sarcoma")
Statistical Report: 2002 (includes "A Closer Look: Melanoma")
Statistical Report: 2001 (includes "A Closer Look: Pancreatic Cancer")
Statistical Report: 2000 (includes "A Closer Look: Oral, Head/Neck Cancer")

Cancer Incidence, All Organs/Sites
Tables show organ/site, class (analytic or non-analytic), gender, and stage of disease.
UCSF Overall, 2006 (PDF)
UCSF Overall, 2005 (PDF)
UCSF Overall, 2004 (PDF)
UCSF Overall, 2003 (PDF)
UCSF Overall, 2002 (Excel)
for previous years see the archive

Staging Forms
AJCC Cancer Staging Forms 6th Ed. [2003]

Investigator Data Requests
Available data sets from the Cancer Registry
Data Request Form, to be submitted with accompanying documentation
UCSF Committee on Human Research

Commission on Cancer
Since 1933, cancer programs at UCSF have been continuously accredited by the Commission on Cancer (CoC) of the American College of Surgeons (ACoS). The CoC is a consortium of professional organizations dedicated to reducing the morbidity and mortality of cancer through education, standard-setting, and monitoring of quality, multidisciplinary cancer patient care. CoC-approved programs diagnose and treat 80 percent of the individuals who are diagnosed with cancer each year.

Cancer programs like those at UCSF voluntarily participate in the CoC Approvals Program, complying with 36 standards of quality cancer patient care. The result is that UCSF is among a select group of institutions that have achieved the highest level of accreditation. Our patients can be assured of: a multi-specialty, comprehensive team approach to coordinate the best treatment options; treatment with state-of-the-art services and equipment; access to the latest clinical trials; and access to cancer-related information, education, and support services.